BIOLASE, Inc. (BIOL)
| Market Cap | 92.37M |
| Revenue (ttm) | 22.78M |
| Net Income (ttm) | -16.83M |
| Shares Out | 61.14M |
| EPS (ttm) | -0.56 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 13 |
| Last Price | $0.580 |
| Previous Close | $0.614 |
| Change ($) | -0.034 |
| Change (%) | -5.46% |
| Day's Open | 0.620 |
| Day's Range | 0.543 - 0.639 |
| Day's Volume | 4,066,124 |
| 52-Week Range | 0.245 - 1.510 |
Reddit penny stocks continue to see momentum; here's 4 to watch with higher than average volume The post 4 Hot Reddit Penny Stocks With Higher Than Average Volume appeared first on Penny Stocks to Buy, ...
FOOTHILL RANCH, Calif., May 6, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2021 financial and operating resu...
IRVINE, Calif., May 6, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today its Waterlase Pediatric Dental Academy (WPDA), for Waterlase pediatric den...
FOOTHILL RANCH, Calif., May 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today sent the following letter to stockholders regarding the upcoming 2021 annual m...
Hot penny stocks to watch during reopening? Check these 3 out The post Reopening Penny Stocks to Buy?
Penny stock watchlists? Why they're not as complicated as they seem The post Penny Stocks Watchlists and How to Make One appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks....
Biotech stocks are more popular than ever; here are 3 to watch under $5 The post Biotech Penny Stocks To Buy? 3 to Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...
Reopening penny stocks that investors are watching right now The post 3 Reopening Penny Stocks to Watch in April 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
BIOLASE Inc (NASDAQ: BIOL) and EdgeEndo have announced the co-development of EdgePRO, a next-generation Laser-Assisted Microfluidic Irrigation device for endodontists. This new Microfluidic Irrigation d...
FOOTHILL RANCH, Calif., April 20, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo , a global leader in commercializing endodontic products, announc...
BABA, BIOL, CTK, GOL, and JKS have been added to the Zacks Rank #5 (Strong Sell) List on April 14, 2021
Dental tech player Biolase has been making moves that have attracted investors, and today BIOL stock is seeing the payoff. The post BIOL Stock: 9 Things to Know As Red-Hot Biolase Rockets Higher appeare...
FOOTHILL RANCH, Calif., March 30, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced a pilot program with Einstein Healthcare Network's residency in ...
FOOTHILL RANCH, Calif., March 25, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ended ...
FOOTHILL RANCH, Calif., March 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2020 financial ...
FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, is sched...
FOOTHILL RANCH, Calif., Feb. 24, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, will be p...
FOOTHILL RANCH, Calif., Feb. 23, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the Board of Directors has appointed John R. Beaver, the Compan...
BIOLASE Inc (NASDAQ: BIOL) has announced to sell 14 million common shares at $1.03 per share, raising $14.4 million in gross proceeds. The offering price represents a discount of 15% from the last close...
IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group LLC und...
FOOTHILL RANCH, Calif., Feb. 4, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today received official notification from the Listing Qualifications Department of th...
FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned special ...
While most of Wall Street focuses on large- and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Biolase (BIOL) stock is flying high on Tuesday after announcing a massive deal for its dental lasers with Dental Care Alliance. The post BIOL Stock Alert: 14 Things for Potential Investors to Know About...
This article is going to explain what penny stocks are and discuss four penny stocks under $1 to watch as small-cap stocks continue a hot streak this winter. First thing's first, what are penny stocks?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 817 13F fi...
FOOTHILL RANCH, Calif., Nov. 13, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the Benchmark Company Discov...
BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q3 2020 Results - Earnings Call Transcript
FOOTHILL RANCH, Calif., Nov. 5, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2020 financial and operating res...
FOOTHILL RANCH, Calif., Oct. 27, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has made available an updated corporate presentation and b...
FOOTHILL RANCH, Calif., Oct. 14, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced unaudited preliminary revenue results for the third quarter ended ...
FOOTHILL RANCH, Calif., Sept. 11, 2020 /PRNewswire/ -- BIOLASE, Inc.
FOOTHILL RANCH, Calif., Aug. 18, 2020 /PRNewswire/ -- BIOLASE, Inc.
BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q2 2020 Results - Earnings Call Transcript
FOOTHILL RANCH, Calif., Aug. 13, 2020 /PRNewswire/ -- BIOLASE, Inc.
FOOTHILL RANCH, Calif., Aug. 6, 2020 /PRNewswire/ -- BIOLASE, Inc.
IRVINE, Calif., July 22, 2020 /PRNewswire/ -- BIOLASE, Inc.
IRVINE, Calif., July 16, 2020 /PRNewswire/ -- BIOLASE, Inc.
IRVINE, Calif., July 13, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced data published in the Journal of Periodontology from a clinical trial cond...
IRVINE, Calif., July 9, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a panel disc...
IRVINE, Calif., July 2, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the subscription period for the rights offering has commenced. If exerci...
IRVINE, Calif., June 22, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today provided an informational update to stockholders regarding its proposed rights offerin...
IRVINE, Calif., June 11, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the closing on June 10, 2020 of its previously announced registered direct...
IRVINE, Calif., June 8, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into a securities purchase agreement with institutional...
BIOLASE Inc (BIOL) CEO Todd Norbe on Q1 2020 Results - Earnings Call Transcript
BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q4 2019 Results - Earnings Call Transcript
BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q3 2019 Results - Earnings Call Transcript
BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q2 2019 - Earnings Call Transcript
Lower investment in MedTech might prove to be a concern, more so as gains within this space are staggering.
Biolase's (BIOL) CEO Todd Norbe on Q1 2019 Results - Earnings Call Transcript
About BIOL
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems for ... [Read more...]
| Industry Medical Devices | IPO Date Nov 13, 1992 |
| CEO Todd Norbe | Employees 135 |
| Stock Exchange NASDAQ | Ticker Symbol BIOL |
Financial Performance
In 2020, BIOLASE, Inc.'s revenue was $22.78 million, a decrease of -39.73% compared to the previous year's $37.80 million. Losses were -$16.83 million, -5.75% less than in 2019.
Analyst Forecasts
According to 4 analysts, the average rating for BIOLASE, Inc. stock is "Buy." The 12-month stock price forecast is 1.94, which is an increase of 234.48% from the latest price.